Also known as ACP-196, Example 6 [US20140155385 A1]
Acalabrutinib, sold under the brand name Calquence, is an anti-cancer medication used to treat various types of non-Hodgkin lymphoma, including mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma. It may be used both in relapsed as well as in treatment-naive settings.
{{Infobox drug | image = Acalabrutinib.svg | image_class = skin-invert-image | width = | alt = | caption =
| pronounce = | tradename = Calquence | Drugs.com = | MedlinePlus = a618004 | DailyMedID = Acalabrutinib | pregnancy_AU = C | pregnancy_AU_comment = | pregnancy_category= | routes_of_administration = By mouth | class = | ATC_prefix = L01 | ATC_suffix = EL02 | ATC_supplemental =
via Wikipedia infobox
via Wikidata sitelinks · CC0
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).